$BOLD
Boundless Bio, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · La Jolla, CA
BOLD chart
What traders are saying about $BOLD
Latest postsBoundless Bio, Inc. news
- Form 4 Boundless Bio Inc: Kevin Tang (10% Owner) For: 3 November
Investing.com Nigeria ·
- Boundless Bio director Kevin Tang buys $26,788 in company shares
Investing.com ·
- Boundless Bio director Kevin Tang buys $25,696 in shares
Investing.com ·
- At $2.40 per share, Boundless Bio (BOLD) owners buy 11,162 shares.
Stock Titan ·
- Boundless Bio, Inc. (BOLD) Seasonal returns chart - Yahoo Finance
Yahoo Finance Singapore ·
- Callio Therapeutics Appoints Chris Hassig, PhD, as Chief Scientific Officer
Yahoo Finance ·
- Callio Therapeutics Appoints Zachary Hornby as Chief Executive Officer
Yahoo Finance ·
- Why Did BOLD, BLZE, QNT Stocks Surge To 52-Week Highs Today
stocktwits.com ·
- BOLD Stock Is Up 90% — Here's What's Behind The Biggest Rally In Company History
stocktwits.com ·
- Boundless Bio and Serapha Bio Announce Merger Agreement and $230 Million Concurrent Private Placement
Yahoo Finance ·
- Boundless Bio Reports First Quarter 2026 Financial Results and Business Highlights
Yahoo Finance ·
- Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting
Yahoo Finance ·
Boundless Bio, Inc. key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net income | -$58.2M | -$65.4M | -$49.4M |
| Diluted EPS | $-2.60 | $-3.85 | $-40.65 |
| Total assets (year end) | $157.1M | $206.4M | $129.9M |
| Cash and equivalents (year end) | $17.9M | $26.6M | $23.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Boundless Bio, Inc.
- Ticker
- BOLD (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- La Jolla, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1782303
Frequently asked questions
What exchange is Boundless Bio, Inc. listed on?
Boundless Bio, Inc. trades on the Nasdaq under the ticker symbol BOLD.
What industry is Boundless Bio, Inc. in?
Boundless Bio, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Boundless Bio, Inc. headquartered?
Boundless Bio, Inc.'s business address on file with the SEC is in La Jolla, CA.
When does Boundless Bio, Inc.'s fiscal year end?
Boundless Bio, Inc.'s fiscal year ends on December 31.